No headlines found.
PRNewswire (Wed, 18-Feb 8:00 AM ET)
PRNewswire (Tue, 10-Feb 8:00 AM ET)
SenesTech's Evolve Approved in New Zealand
PRNewswire (Mon, 2-Feb 8:00 AM ET)
SenesTech Announces CEO Transition Plan
PRNewswire (Wed, 28-Jan 4:05 PM ET)
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
Senestech trades on the NASDAQ stock market under the symbol SNES.
As of February 27, 2026, SNES stock price declined to $2.25 with 5,080 million shares trading.
SNES has a beta of 2.32, meaning it tends to be more sensitive to market movements. SNES has a correlation of 0.23 to the broad based SPY ETF.
SNES has a market cap of $11.75 million. This is considered a Sub-Micro Cap stock.
Last quarter Senestech reported $690,000 in Revenue and -$.28 earnings per share. This fell short of revenue expectation by $-40,000 and exceeded earnings estimates by $.07.
In the last 3 years, SNES traded as high as $290.40 and as low as $1.30.
The top ETF exchange traded funds that SNES belongs to (by Net Assets): VXF, VTI.
SNES has underperformed the market in the last year with a return of -28.8%, while the SPY ETF gained +18.5%. In the last 3 month period, SNES fell short of the market, returning -19.9%, while SPY returned +1.2%. However, in the most recent 2 weeks SNES has outperformed the stock market by returning +12.5%, while SPY returned +0.6%.
SNES support price is $2.09 and resistance is $2.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNES shares will trade within this expected range on the day.